Post-Market Study of the ICONACY Hip System

ICONACY Hip Clinical Data Acquisition (13-1-M-239)

The purpose of this study is to evaluate the use and efficacy of the Iconacy Hip System for total hip replacement surgery.

Inclusion Criteria:

• This must be a primary hip replacement on this hip
• Patient is 30 years of age or older
• Have hip joint disease related to one or more of the following: degenerative joint disease, including osteoarthritis or traumatic arthritis
• Patient is likely to be available for evaluation for the duration of the study
• Able and willing to sign the informed consent and follow study procedures

Exclusion Criteria:

• Is younger than 30 years of age
• If there has been a total hip replacement on this hip in the past (no revisions allowed in study)
• Infection, or history of infection, acute or chronic, local or systemic
• Alcoholism or other addictions
• Muscular, neurological or vascular deficiencies which compromise the affected extremity
• Obesity(BMI>45)
• Insufficient bone quality
• Loss of ligamentous structures
• High levels of physical activity
• Materials sensitivity
• Prisoner
• Mental conditions that may interfere with the patient's ability to give an informed consent or willingness to fulfill the study requirements
• Patient is pregnant
• Is not able to read English language